InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,168.00
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.86
(
0.46%
)
Bitcoin
60,748.38
(
-0.11%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Just the facts maam

Send PM Follow Ignore
Followers 20
Posts 5376
Boards Moderated 0
Alias Born 01/04/2012

Just the facts maam

Re: senderos post# 11971

Sunday, 02/19/2012 11:01:22 AM

Sunday, February 19, 2012 11:01:22 AM

Post# of 26138
You are correct it is only an application at this point. But it is the information within the application about CV efficacy which should make us sit up and take notice. At least 70% risk reduction in CV events

As for the patent application this an area where they excel, based on the Patent Board's Scorecard ratings for Biosante the last couple of years, they are well versed in the process of obtaining patents and very capable of obtaining this one.

Top 15 2010

I would love to be a fly on the wall at the FDA meetings.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up